Lantheus Holdings, Inc(LNTH)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$104.52
52-Week Range
$47.25 – $104.57
YTD
+55.37%
IV Rank (30D)
28.01
Straddle Price
$10.35
P/C Vol Ratio
0.55
Market Cap
$6.8B
Fair Value
-13.7% vs price
Confidence: 67% Alpha Score: 0.11

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.53%
Beta vs SPY1.00
Cost of Equity (CAPM)10.03% (VRP-adj)
WACC9.58%
Volatility Risk Premium+57.1pp (IV − HV30), ERP adj +50bps
Effective Tax Rate25.3%
Rev. Growth (YoY, DCF input)-0.2%
DCF Horizon12 years explicit + fade
Free Cash Flow (TTM)$0.4B
Return on Equity (TTM)23.0%
Book / Price17.1%
Gross Margin (TTM)60.5%
FCF Margin (TTM)24.4%
Debt / Equity0.47
Quality Score5/6 — high quality (12y DCF)
Market-Implied Growth+6.8% (reverse-DCF on current price)
SMA 50$89.99 (Market Anchor value)
SMA 20 / Bollinger Mid$98.51
Bollinger Width / SMA2013.3% (drives anchor stability)
Net Debt$0.1B
Market Cap$7B
Peers used for multiples: CRS, EXEL, FTI, HALO, MSA, RMBS, STRL, UTHR
Blended Fair Value
$90.23
Current Price
$104.52
Deviation
-13.7%
Forward-Return Rank SHORT gated
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -1.7% +0.38 -0.60 59.8%
42d -2.2% +0.52 -0.60 59.8%
63d -2.1% +0.49 -0.60 59.8%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF $66.73 25%
DDM (Gordon) n/a 0%
Peer P/E $102.96 11% median 24.9× · 8 peers
Peer EV/EBITDA $77.66 11% median 14.5× · 8 peers
Peer P/B $169.33 2% median 9.5× · 8 peers
Peer P/S $145.99 8% median 6.4× · 8 peers
Market Anchor (SMA50) $89.99 43% stability 85% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-12 · updated 2026-06-12 20:59:55.687000
Info
Industry (SIC)
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (2835)
Exchange
XNAS
Market Cap
$6.8B

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and …

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan -2.55% 11
Feb +18.19% 11
Mar +1.62% 11
Apr +8.67% 11
May +2.06% 11
Jun +10.75% 12
Jul +4.86% 11
Aug +10.12% 11
Sep -4.66% 11
Oct -4.48% 11
Nov +6.76% 11
Dec -4.58% 11
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $98.91
SMA 50: $90.56
SMA 200: $69.89
Current: $104.52
EMA 12: $100.69
EMA 26: $97.23
MACD: 3.4607 | Signal: -0.0338
BULLISH
ADX (14): 44.07
STRONG TREND
+DI: 24.71
−DI: 9.69
Momentum Oscillators
RSI (14): 67.14
NEUTRAL
Stoch %K: 87.25
Stoch %D: 76.43
Williams %R: -0.52
Volume & Volatility
BB Upper: $105.79
BB Lower: $92.02
NEUTRAL
OBV: 796,874
Vol SMA 20: 1,045,657
Vol ROC: -50.06%
ATR: $3.53
True Range: $1.92
HV 20: 45.1%
HV 30: 41.3%
HV 60: 36.3%

Data Summary
Data Points: 500
Last Updated: 2026-06-13T13:41:32.506000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
5 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-07-31 Pre-Market 11.30% 6.18% 0.55x Within
2024-11-06 Pre-Market 12.17% 21.16% 1.74x Exceeded
2025-02-26 Pre-Market 19.18% 16.49% 0.86x Within
2025-05-07 Pre-Market 14.55% 23.01% 1.58x Exceeded
2025-08-06 Pre-Market 15.76% 28.54% 1.81x Exceeded
2025-11-06 Pre-Market 19.44% 6.13% 0.32x Within
2026-02-26 Pre-Market 15.43% 0.26% 0.02x Within
2026-05-07 Pre-Market 12.36% 5.63% 0.46x Within
Options Activity
IV Rank (30D)
28.01
IV Rank (7D)
100
Avg IV
63.7%
Straddle (30D)
$10.35
Straddle (7D)
$4.08
P/C Volume
0.55
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.52
Correlation (SPY)
13.6%
0.02
Ann. Volatility
47.4%
SPY Volatility
12.3%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 68,047,500 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

444 filers630,283,212 shares$5.51B value926.24% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 17,283,193 $631.61M 11.47% 25.40% 2026-03-31
2 VANGUARD GROUP INC Custodian 6,699,381 $445.84M 8.09% 9.85% 2025-12-31
3 JANUS HENDERSON GROUP PLC 4,774,841 $362.17M 6.57% 7.02% 2026-03-31
4 FMR LLC Custodian 11,133,453 $358.72M 6.51% 16.36% 2026-03-31
5 STATE STREET CORP 14,579,803 $198.93M 3.61% 21.43% 2026-03-31
6 AMERICAN CENTURY COMPANIES INC 1,781,106 $135.10M 2.45% 2.62% 2026-03-31
7 GEODE CAPITAL MANAGEMENT, LLC Custodian 1,765,952 $133.97M 2.43% 2.60% 2026-03-31
8 MORGAN STANLEY Custodian 9,468,569 $125.79M 2.28% 13.91% 2025-12-31
9 REINHART PARTNERS, LLC. 1,564,878 $118.70M 2.15% 2.30% 2026-03-31
10 DIMENSIONAL FUND ADVISORS LP Custodian 1,379,570 $104.63M 1.90% 2.03% 2026-03-31
11 Swedbank AB 1,228,743 $93.20M 1.69% 1.81% 2026-03-31
12 TD ASSET MANAGEMENT INC 1,133,518 $85.98M 1.56% 1.67% 2026-03-31
13 BRIGADE CAPITAL MANAGEMENT, LP 49,123,745 $85.85M 1.56% 72.19% 2026-03-31
14 WELLINGTON MANAGEMENT GROUP LLP Custodian 16,212,850 $76.95M 1.40% 23.83% 2026-03-31
15 Carmignac Gestion 1,122,000 $74.67M 1.36% 1.65% 2025-12-31
16 Point72 Asset Management, L.P. 974,210 $73.89M 1.34% 1.43% 2026-03-31
17 UBS Group AG Custodian 914,005 $65.87M 1.20% 1.34% 2026-03-31
18 NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1,911,417 $65.03M 1.18% 2.81% 2026-03-31
19 DEERFIELD MANAGEMENT COMPANY, L.P. 827,999 $62.80M 1.14% 1.22% 2026-03-31
20 MACKAY SHIELDS LLC 50,898,000 $61.20M 1.11% 74.80% 2026-03-31
21 NORTHERN TRUST CORP Custodian 804,923 $61.05M 1.11% 1.18% 2026-03-31
22 BANK OF AMERICA CORP /DE/ Custodian 13,792,646 $56.23M 1.02% 20.27% 2026-03-31
23 WOLVERINE ASSET MANAGEMENT LLC 46,438,000 $55.71M 1.01% 68.24% 2026-03-31
24 JPMORGAN CHASE & CO Custodian 2,128,473 $55.68M 1.01% 3.13% 2026-03-31
25 MACKENZIE FINANCIAL CORP 714,561 $54.20M 0.98% 1.05% 2026-03-31
7 filers$28.73M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $12.26M 42.66% 2026-03-31
2 BRIGADE CAPITAL MANAGEMENT, LP $7.58M 26.40% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $3.45M 12.01% 2026-03-31
4 JANE STREET GROUP, LLC Custodian $2.04M 7.10% 2026-03-31
5 Cubist Systematic Strategies, LLC $1.75M 6.11% 2025-09-30
6 WOLVERINE TRADING, LLC Custodian $1.26M 4.37% 2025-09-30
7 Point72 Asset Management, L.P. $386.83K 1.35% 2026-03-31
5 filers$18.93M notional
# Filer Notional Value % of Total Period
1 CITADEL ADVISORS LLC Custodian $6.64M 35.05% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $6.35M 33.53% 2026-03-31
3 JANE STREET GROUP, LLC Custodian $4.07M 21.51% 2026-03-31
4 WOLVERINE TRADING, LLC Custodian $1.12M 5.91% 2025-09-30
5 LOGAN CAPITAL MANAGEMENT INC $757.13K 4.00% 2026-03-31
Insider Activity
Latest: 2026-06-03
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-03 Mary Anne Heino Executive Chair and CEO Tax (F) −1,227 $96.67 -$118.6K EDGAR
2026-06-03 Gerard Ber Director Tax (F) −381 $96.67 -$36.8K EDGAR
2026-05-18 JULIA MARIE EASTLAND Director Award (A) +4,137 EDGAR
2026-05-18 James H Thrall Director Award (A) +4,137 EDGAR
2026-05-18 Gerard Ber Director Award (A) +4,137 EDGAR
2026-05-18 Minnie Baylor-Henry Director Award (A) +4,137 EDGAR
2026-05-18 Gary J Pruden Director Award (A) +4,137 EDGAR
2026-05-18 SAM R LENO Director Award (A) +4,137 EDGAR
2026-05-18 Heinz Christoph Maeusli Director Award (A) +4,137 EDGAR
2026-05-18 Phuong Khanh Morrow Director Award (A) +4,137 EDGAR
2026-05-18 Julie McHugh Director Award (A) +4,137 EDGAR
2026-04-21 Daniel Niedzwiecki See Remarks Tax (F) −1,911 $83.82 -$160.2K EDGAR
2026-03-09 Amanda Michelle Morgan Chief Commercial Officer Mixed +25,613 $76.31 -$45.4K EDGAR
2026-03-09 Kimberly Brown Chief Accounting Officer Mixed +6,025 $76.31 -$10.1K EDGAR
2026-03-09 Robert J. Jr. Marshall CFO and Treasurer Mixed +36,820 $76.31 -$90.2K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
43 insiders · @ $104.52
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Sriram Venkataraman Director 7,004,395 $732.10M -$59.10M 2 2017-03-21
2 MARK C WEHRLY 6,842,227 $715.15M -$1.53B 1 2025-08-21
3 Avista Capital Partners GP, LLC 10%+ Owner 5,295,117 $553.45M -$307.20M 2 2017-05-11
4 ACP-Lantern Co-Invest, LLC 10%+ Owner 3,585,838 $374.79M -$268.44M 2 2017-06-22
5 FARALLON PARTNERS L L C/CA 10%+ Owner 3,477,227 $363.44M -$1.91B 1 2025-08-21
6 Mary Anne Heino Executive Chair and CEO 330,515 $34.55M -$44.93M 61 2026-06-03
7 David F Burgstahler Director 260,501 $27.23M -$154.91M 9 2017-09-11
8 BRIAN A MARKISON CEO 232,420 $24.29M -$6.52M 32 2025-03-07
9 Jeffrey Allen Bailey CEO and President 229,407 $23.98M $0 4 2015-09-03
10 John W. Crowley CFO 161,825 $16.91M -$215.3K 16 2018-04-27
11 Robert J. Jr. Marshall CFO and Treasurer 122,792 $12.83M -$14.08M 36 2026-03-09
12 Avista Capital Partners, L.P. 10%+ Owner 122,492 $12.80M -$9.73M 1 2017-08-16
13 Daniel Niedzwiecki See Remarks 117,465 $12.28M -$4.78M 29 2026-04-21
14 William C. Jr. Dawes VP, Mfg & Ops 111,581 $11.66M $0 8 2017-09-01
15 MICHAEL P DUFFY SVP and General Counsel 109,472 $11.44M -$4.08M 37 2021-04-20
16 Paul Blanchfield President 108,214 $11.31M -$4.20M 30 2025-08-15
17 John J. Bolla Chief Operations Officer 102,440 $10.71M -$276.6K 10 2021-06-21
18 Etienne Montagut Chief Business Officer 94,651 $9.89M -$4.93M 15 2024-03-07
19 Cesare Orlandi Chief Medical Officer 88,501 $9.25M -$2.32M 22 2019-07-10
20 Timothy G Healey SVP, Commercial 85,658 $8.95M -$456.3K 8 2018-03-07
21 SAM R LENO Director 67,246 $7.03M -$3.02M 24 2026-05-18
22 Carol Walker Senior Vice President, Quality 64,899 $6.78M -$1.34M 4 2022-04-01
23 Amanda Michelle Morgan Chief Commercial Officer 64,153 $6.71M $0 5 2026-03-09
24 James C Clemmer Director 62,082 $6.49M $0 6 2020-03-05
25 Andrea Sabens Chief Accounting Officer 60,420 $6.32M -$2.07M 36 2024-07-17
26 Istvan Molnar Chief Medical Officer 58,950 $6.16M -$74.1K 2 2021-03-08
27 A Frederick Robertson Director 51,798 $5.41M -$131.7K 12 2021-04-30
28 James H Thrall Director 39,881 $4.17M -$273.0K 15 2026-05-18
29 Jean-Claude Provost Chief Medical Officer 38,841 $4.06M $0 3 2024-03-07
30 Ludger Dinkelborg See Remarks 35,731 $3.73M $0 2 2026-03-09
31 Julie McHugh Director 30,099 $3.15M -$1.34M 22 2026-05-18
32 Heinz Christoph Maeusli Director 30,014 $3.14M -$1.31M 19 2026-05-18
33 Gerard Ber Director 27,118 $2.83M -$1.57M 15 2026-06-03
34 DERACE L SCHAFFER Director 25,089 $2.62M -$1.62M 12 2020-03-05
35 Kenneth Pucel Director 21,359 $2.23M $0 3 2020-03-05
36 Ying Vivian Yao Chief Human Resources Officer 19,054 $1.99M $0 1 2022-03-07
37 Gary J Pruden Director 15,123 $1.58M -$1.26M 15 2026-05-18
38 Patrick O'Neill Director 14,382 $1.50M $0 1 2015-06-25
39 Minnie Baylor-Henry Director 14,034 $1.47M -$517 8 2026-05-18
40 Kimberly Brown Chief Accounting Officer 13,726 $1.43M $0 4 2026-03-09
41 Jeffrey Humphrey Chief Medical Officer 9,076 $948.6K $0 1 2024-06-20
42 JULIA MARIE EASTLAND Director 8,019 $838.1K $0 3 2026-05-18
43 Phuong Khanh Morrow Director 7,237 $756.4K $0 4 2026-05-18
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Recent SEC Filings
Latest: 2026-05-07
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-07 0001193125-26-210369 EDGAR
2026-05-01 0001193125-26-201556 EDGAR
2026-02-26 0001193125-26-073439 EDGAR
2025-11-12 0001193125-25-277754 EDGAR
2025-11-06 0001193125-25-268103 EDGAR
2025-08-11 0001193125-25-178046 EDGAR
2025-08-06 0000950170-25-103543 EDGAR
2025-07-22 0001193125-25-162233 EDGAR
2025-05-07 0001628280-25-022871 EDGAR
2025-05-05 0001193125-25-112812 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-26 0001193125-26-073498 EDGAR
2025-02-26 0001628280-25-007970 EDGAR
2024-02-22 0001628280-24-006158 EDGAR
2023-02-23 0001628280-23-004698 EDGAR
2022-02-24 0001628280-22-003657 EDGAR
2021-02-25 0001628280-21-003336 EDGAR
2020-02-25 0001628280-20-002197 EDGAR
2019-02-20 0001628280-19-001574 EDGAR
2018-02-26 0001628280-18-002261 EDGAR
2017-02-23 0001193125-17-053986 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-07 0001193125-26-210373 EDGAR
2025-11-06 0001193125-25-268113 EDGAR
2025-08-06 0000950170-25-103544 EDGAR
2025-05-07 0001628280-25-022872 EDGAR
2024-11-06 0001628280-24-045459 EDGAR
2024-07-31 0001628280-24-033630 EDGAR
2024-05-02 0001628280-24-019798 EDGAR
2023-11-02 0001628280-23-036214 EDGAR
2023-08-03 0001628280-23-027015 EDGAR
2023-05-04 0001628280-23-015464 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio25.2
P/B Ratio5.6
P/S Ratio4.4
EV/EBITDA18.6
TTM Revenue$1.5B
TTM Net Income$0.3B
TTM EPS$4.14
ROE23.0%
Debt/Equity0.47